Phase 2 study of docetaxel in the treatment of childhood refractory acute leukemias: a Children's Oncology Group report. [electronic resource]
Producer: 20080212Description: 533-6 p. digitalISSN:- 1545-5017
- Acute Disease
- Adolescent
- Adult
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Bone Marrow Diseases -- chemically induced
- Child
- Child, Preschool
- Docetaxel
- Drug Administration Schedule
- Female
- Fever -- etiology
- Humans
- Infant
- Infusions, Intravenous
- Leukemia -- drug therapy
- Leukemia, Myeloid -- drug therapy
- Male
- Neutropenia -- chemically induced
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Salvage Therapy
- Taxoids -- administration & dosage
- Treatment Failure
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.